TABLE 1.
Demographic and clinical data of the study population.
| Study population | |
| Age (years) | 62.5(54;69) |
| Gender, male n (%) | 55 (83) |
| BMI | 26.12(24.69;27.1) |
| Creatinine (mg/dl) | 0.89(0.73;1.0) |
| Glucose (mg/dl) | 133(117;163) |
| Cholesterol (mg/dl) | 180(156;213) |
| Myoglobin (ng/ml) | 183(67;324) |
| Creatine kinase MB (U/l) | 64(19;113) |
| Troponin I (ng/ml) | 0.6(0.11;3.8) |
| GFR (ml/min) | 92(72;103) |
| Hypertension, n (%) | 37 (56.1) |
| Diabetes, n (%) | 12 (18.2) |
| Smokers, n (%) | 53 (80.3) |
| Dyslipidemia, n (%) | 15 (22.7) |
| Beta blockers, n (%) | 4 (6.1) |
| Calcium antagonists, n (%) | 7 (10.6) |
| ACE inhibitors, n (%) | 20 (30.3) |
| Sartan, n (%) | 1 (1.5) |
| Statin, n (%) | 4 (6.1) |
| Antiaggregants, n (%) | 6 (9.1) |
| PTCA LAD, n (%) | 32 (48.5) |
| PTCA CX, n (%) | 6 (9.1) |
| PTCA RCA, n (%) | 29 (43.9) |
BMI, body mass index; GFR, glomerular filtration rate; ACE, angiotensin-converting enzyme; PTCA, percutaneous transluminal coronary angioplasty; LAD, left anterior descending artery; CX, circumflex artery; RCA, right coronary artery.